Research and Markets: Global Peptide Therapeutics Market 2014-2018

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/922ws9/global_peptide) has announced the addition of the "Global Peptide Therapeutics Market 2014-2018" report to their offering.

The Global Peptide Therapeutics market to grow at a CAGR of 9.25% over the period 2013-2018

Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Peptides are used to control, trigger, and maintain physiological processes in living beings. However, the use of peptides as therapeutic agents has always been difficult because of their inherent instability and incapability to cross cellular membranes.

Peptides also entail the requirement of specific technology to tackle the extensive and challenging steps in their synthesis. Currently, there are more than 80 peptides marketed by various companies. These companies explore the probability of designing and engineering peptides that overcome their natural confines and allow these potent chemical entities to be used as therapeutic agents.

One key trend upcoming in the market is the growing popularity of peptide therapeutics in the market, which results in increased consumption of peptide drugs, thereby affecting market growth.

According to the report, the major driving factor of this market is the increase in patient populations suffering from various diseases in many countries. This causes an increase in the consumption of peptide medicines, thereby boosting market growth.

Further, the report states that the high cost of therapy is a major challenge to the growth of the market. It results in a decrease in the rate of patients seeking treatment in the market, which restrains the growth.

Key Vendors

  • AstraZeneca
  • Eli Lilly
  • Novo Nordisk
  • Sanofi

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Route of Administration
  8. Market Segmentation by Drug Class
  9. Market Segmentation by Technology
  10. Geographical Segmentation
  11. Peptide Synthesis
  12. Optimization of Peptides
  13. Stabilization of Peptides
  14. Buying Criteria
  15. Market Growth Drivers
  16. Drivers and their Impact
  17. Market Challenges
  18. Impact of Drivers and Challenges
  19. Market Trends
  20. Trends and their Impact
  21. Vendor Landscape
  22. Pipeline Portfolio
  23. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/922ws9/global_peptide

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals